These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 10674133)

  • 1. Primary neuroendocrine carcinoma of the liver: difficult diagnosis of a rare neoplasm.
    Ferrero A; Gallino C; D'Aloisio G; Gandini G; Garavoglia M
    Acta Chir Belg; 1999 Dec; 99(6):299-302. PubMed ID: 10674133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver resection for primary hepatic neuroendocrine tumours: report of three cases and review of the literature.
    Donadon M; Torzilli G; Palmisano A; Del Fabbro D; Panizzo V; Maggioni M; Santambrogio R; Montorsi M
    Eur J Surg Oncol; 2006 Apr; 32(3):325-8. PubMed ID: 16426802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases.
    Huang YQ; Xu F; Yang JM; Huang B
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):44-8. PubMed ID: 20133228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hepatic neuroendocrine tumor: an unusual cystic presentation.
    Shetty PK; Baliga SV; Balaiah K; Gnana PS
    Indian J Pathol Microbiol; 2010; 53(4):760-2. PubMed ID: 21045409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-directed therapies for metastatic neuroendocrine tumors.
    Garrot C; Stuart K
    Hematol Oncol Clin North Am; 2007 Jun; 21(3):545-60; ix-x. PubMed ID: 17548039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive techniques in management of hepatic neuroendocrine metastatic disease.
    Liu DM; Kennedy A; Turner D; Rose SC; Kee ST; Whiting S; Murthy R; Nutting C; Heran M; Lewandowski R; Knight J; Gulec S; Salem R
    Am J Clin Oncol; 2009 Apr; 32(2):200-15. PubMed ID: 19346815
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemoembolization of hepatic malignancies.
    Soulen MC
    Oncology (Williston Park); 1994 Apr; 8(4):77-84; discussion 84, 89-90 passim. PubMed ID: 8003400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study.
    Maire F; Lombard-Bohas C; O'Toole D; Vullierme MP; Rebours V; Couvelard A; Pelletier AL; Zappa M; Pilleul F; Hentic O; Hammel P; Ruszniewski P
    Neuroendocrinology; 2012; 96(4):294-300. PubMed ID: 22507901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.
    Park CH; Chung JW; Jang SJ; Chung MJ; Bang S; Park SW; Song SY; Chung JB; Park JY
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1306-11. PubMed ID: 22414232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine liver metastases.
    Reddy SK; Clary BM
    Surg Clin North Am; 2010 Aug; 90(4):853-61. PubMed ID: 20637952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transhepatic artery chemoembolization for liver metastases of primary retroperitoneal endodermal sinus tumor. A case report.
    Chen CL; Wang PH; Ng HT; Yuan CC
    J Reprod Med; 1999 Jun; 44(6):559-62. PubMed ID: 10394553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case.
    Ishida M; Seki K; Tatsuzawa A; Katayama K; Hirose K; Azuma T; Imamura Y; Abraham A; Yamaguchi A
    Surg Today; 2003; 33(3):214-8. PubMed ID: 12658390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
    Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
    Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Locoregional therapy of neuroendocrine tumors].
    Roche A; Lasser P
    Rev Prat; 2002 Feb; 52(3):274-8. PubMed ID: 11925717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for unresectable neuroendocrine liver metastases.
    John BJ; Davidson BR
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?
    Nakakura EK; Venook AP; Bergsland EK
    Surg Oncol Clin N Am; 2007 Jul; 16(3):639-51, x. PubMed ID: 17606198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.
    Christante D; Pommier S; Givi B; Pommier R
    Surgery; 2008 Dec; 144(6):885-93; discussion 893-4. PubMed ID: 19040993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liver transplantation in neuroendocrine tumors prolongs symptom-free period, might also be a cure].
    Olausson M; Friman S; Johanson V; Nilsson O; Wängberg B; Ahlman H
    Lakartidningen; 1999 Sep; 96(36):3783-6. PubMed ID: 10500396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
    Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
    J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.